InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by KIES PETER, Chief Financial Officer. Director active across 2 companies, notably INOVIO PHARMACEUTICALS, INC.. Aggregated, 7 reports have been recorded. Total volume traded: €132k. The latest transaction was filed on 9 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
59,737 shares
Common Stock
SEC:0001055726-22-000019:0·
21,466 shares
Common Stock
SEC:0001055726-22-000017:0·
22,545 shares
Common Stock
SEC:0001055726-22-000012:0·
€24,38013,750 shares@ €1.773126.9% of flow
Common Stock
SEC:0001055726-21-000050·
€24,38013,750 shares@ €1.77310.023% mcap26.9% of flow
Common Stock
SEC:0001055726-21-000050:0·
€66,18310,000 shares@ €6.618373.1% of flow
Common Stock
SEC:0001055726-21-000049·
€66,18310,000 shares@ €6.61830.062% mcap73.1% of flow
Common Stock
SEC:0001055726-21-000049:0·
7 of 7 declarations
About KIES PETER
Peter Kies is the Chief Financial Officer at Inovio Pharmaceuticals, Inc. He oversees the financial management of the company, including budgeting and financial analysis. His role is crucial for ensuring the financial health of Inovio.
